MSN Laboratories, is one of the fastest growing pharmaceutical manufacturers of APIs and finished dosages in India. We have 8 API and 3 Finished dosage facilities & an integrated R&D Center located in Hyderabad. Our state-of-the-art facilities are accredited by PIC/S, USFDA, EU:GMP, WHO:Geneva, Invima and many other global approvals. With a product portfolio covering 35 major therapies including Oncology, MSN reaches out to millions of people in 65 countries across North America, Europe, Latin America, CIS, Middle East, Africa & Asia. Our strengths are our world-class facilities, innovation driven R&D, strong IPM, commitment to quality, efficient supply chain and a team with proven track record. MSN is proud to launch 1st-in-the-World Generics for 11 state-of-the-art-medicines at affordable prices; file 300 patents, 303 DMFs/CEPs , 1500 Formulation Dossiers & ANDAs. With annual capacities over 4 Billion units for the Oral Solids, Injectibles and Oncologics, we support 250 partners across 65 countries in the API and Formulations business. Integrity, Imagination and Innovation are the ingredients of our organizational culture. With an outstanding workforce, cutting-edge science, state-of-the-art technology and knowledge intensive initiatives, we are working on innovative solutions for tomorrow`s healthcare challenges.